Population aging is a global phenomenon, and while not as critical as finding cures for cancer or rare diseases, anti-aging therapies – a branch of regenerative medicine – have consistently intrigued researchers, investors, and biotech entrepreneurs for the last decade.

If there’s one thing that remains constant in biotech, it’s the ability of companies to adapt and evolve relative to available resources and current limitations….

With JPM 2022 having finished up last week, new standout partnerships between promising biotech companies and profitable big pharma show that reciprocity between players…

The growing biopharmaceutical market in China has become increasingly appealing to international entrepreneurs and investors, with recent…